Published in PLoS One on November 13, 2014
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
Low-dose radiation modulates human mesenchymal stem cell proliferation through regulating CDK and Rb. Am J Transl Res (2017) 0.75
Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis. BMC Med Genomics (2017) 0.75
Pre-eclampsia. Lancet (2005) 10.41
Latest advances in understanding preeclampsia. Science (2005) 8.11
Pre-eclampsia. Lancet (2010) 7.46
ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol (2002) 7.40
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol (1999) 4.74
Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med (2010) 3.81
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation (2003) 2.15
Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ (2009) 2.14
The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol (2010) 1.99
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation (2012) 1.88
IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta (2014) 1.87
Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens (1991) 1.86
Differential placental gene expression in severe preeclampsia. Placenta (2009) 1.85
Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol (2007) 1.47
The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol (2003) 1.41
Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta (2006) 1.39
Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol (2007) 1.28
Gabor Than Award Lecture 2008: pre-eclampsia - from placental oxidative stress to maternal endothelial dysfunction. Placenta (2008) 1.24
Preeclampsia 2012. J Pregnancy (2012) 1.20
The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells. Nutr Cancer (2009) 1.13
Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet (2002) 1.11
Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med (2011) 1.01
Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. Vasc Cell (2011) 0.99
Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div (2009) 0.99
Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med (2012) 0.98
Prematurity is related to high placental cortisol in preeclampsia. Pediatr Res (2009) 0.95
Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol (2011) 0.95
Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood (1994) 0.94
Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia. Cell Tissue Res (2011) 0.93
Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol (2012) 0.93
Gene expression profiling of placentas affected by pre-eclampsia. J Biomed Biotechnol (2010) 0.93
Regulation of placental growth by aldosterone and cortisol. Endocrinology (2010) 0.92
Preeclampsia and the Anti-Angiogenic State. Pregnancy Hypertens (2011) 0.92
Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost (1998) 0.91
Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Matern Fetal Neonatal Med (2007) 0.91
Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol (2005) 0.91
Increased interaction between heat shock protein 27 and mitogen-activated protein kinase (p38 and extracellular signal-regulated kinase) in pre-eclamptic placentas. J Obstet Gynaecol Res (2009) 0.89
Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarrays. J Pregnancy (2011) 0.89
Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach. Am J Pathol (2011) 0.89
Function-specific intracellular signaling pathways downstream of heparin-binding EGF-like growth factor utilized by human trophoblasts. Biol Reprod (2010) 0.88
CCN3 regulates proliferation and migration properties in Jeg3 trophoblast cells via ERK1/2, Akt and Notch signalling. Mol Hum Reprod (2012) 0.86
Expression of androgen receptor in human placentas from normal and preeclamptic pregnancies. Taiwan J Obstet Gynecol (2009) 0.85
Self-control of HGF regulation on human trophoblast cell invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17. J Clin Endocrinol Metab (2012) 0.85
Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand (1999) 0.83
Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am J Obstet Gynecol (2004) 0.82
Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. Eur Heart J (2011) 0.82
Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor. J Thromb Thrombolysis (2012) 0.82
Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity. Hum Pathol (2011) 0.80
Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia. Am J Obstet Gynecol (2014) 0.80
Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Horm IGF Res (2006) 0.79
Gene expression profiling of bovine peripartal placentomes: detection of molecular pathways potentially involved in the release of foetal membranes. Reproduction (2011) 0.78
[Measuring the concentration of various plasma and placenta extract proteolytic and vascular factors in pregnant patients with HELLP syndrome, pre-/eclampsia and highly pathologic Doppler flow values]. Gynakol Geburtshilfliche Rundsch (1995) 0.78
Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia. Fertil Steril (2012) 0.77
Eliminating first trimester markers: will replacing PAPP-A and βhCG miss women at risk for small for gestational age? J Matern Fetal Neonatal Med (2014) 0.76